Protective Effects of Interferon-tau Against Lipopolysaccharide-Induced Embryo Implantation Failure in Pregnant Mice

Kangfeng Jiang,Jing Yang,Yu Chen,Shuai Guo,Gan Zhao,Haichong Wu,Ganzhen Deng
DOI: https://doi.org/10.1089/jir.2017.0126
2018-01-01
Journal of Interferon & Cytokine Research
Abstract:Interferon-tau (IFN-), a novel type I interferon, is produced by trophoblast cells in ruminants. Previous studies have confirmed that IFN- could induce immunological tolerance in humans and other species. However, there are few reports on whether IFN- has a protective effect on embryo implantation failure caused by excessive inflammation at the maternal-fetal interface. In our study, a mouse model of lipopolysaccharide (LPS)-induced implantation failure was successfully established, and we investigated the protective effects of IFN-. First, we showed that IFN- increased the number of implanted embryos in LPS-treated pregnant mice. Subsequently, quantitative real-time polymerase chain reaction (qPCR) and ELISA results showed that several inflammatory cytokines [IL-1 and tumor necrosis factor-alpha (TNF-)] whose expression was upregulated by LPS were reversed by IFN- treatment. Furthermore, we performed Western blotting and found that IFN- restrained the LPS-induced phosphorylation of IB and NF-B p65. Moreover, qPCR and immunohistochemistry analyses showed that IFN- decreased the LPS-induced expression of mouse major histocompatibility complex (MHC) class I genes (H-2K and H-2D) in LPS-treated pregnant mice. Taken together, these results suggest that IFN- has a protective effect in LPS-induced implantation failure by downregulating MHC class I genes expression and inhibiting the production of inflammatory cytokines.
What problem does this paper attempt to address?